Table 5.
The published SWE studies on sCLNs.
| Study | Pathology |
Cutoff (kPa) |
EI (kPa) |
Sensitivity (%) | Specificity (%) | Accuracy (%) |
|---|---|---|---|---|---|---|
| Bhatia et al. (26) | SCC (11), Lung adenocarcinoma (5), NHL (4), NPC (5), PTC (5), Poorly differentiated carcer (1) |
Emean = 30.2 | Benign: 21.4 and Metastatic: 25 |
41.9 | 100 | 61.8 |
| Choi et al. (27) | PTC (26), Salivary gland carcinoma (1), Hypopharynx SCC (6), Melanoma (1) |
Emax = 19.44 | Benign: Emax = 14.22 ± 4.19 and Metastatic: Emax = 41.06 ± 36.34 |
91 | 97 | 94 |
| Jung et al. (28) | PTC (51) | Emean = 29 | Benign: Emin = 18.70 ± 11.82, Emax = 35.52 ± 29.16, Emean = 27.50 ± 18.95 and Metastatic: Emin = 48.49 ± 47.21, Emax = 79.61 ± 71.23, Emean = 67.93 ± 62.52 |
98 | 45.4 | 77.38 |
| Desmots et al. (29) | Squamous carcinomas (16), papillary thyroid carcinomas (4), head and neck (2), sarcomas (2), lymphomas (2), kidney (2), melanoma (1), malignant paraganglioma (1) Reference standard: pathology | Emax = 31.0 | Benign: Emax = 23.3 ± 25.3 and Metastatic: Emax = 72.4 ± 59.0 |
86.7 | 87.5 | 87.1 |
SWE, Shear wave elastography; sCLNs, Small cervical lymph nodes; NPC, Nasopharyngeal carcinoma; SCC, Squamous cell carcinomas; PTC, Papillary thyroid carcinomas; NHL, Non-Hodgkin lymphoma; EI, Elasticity indices; Emean, Mean elasticity values; Emin, Minimum elasticity values; Emax, Maximum elasticity values.